Why This Concept Deserves More Scrutiny Than It Gets
In my extensive experience, I have found no concept more frequently invoked, more often misunderstood, or more consequential to a claim’s outcome than Maximum Medical Improvement (MMI). Attorneys cite it as a trigger to terminate benefits. Claims adjusters treat it as a green light to close a file. Physicians sometimes use it interchangeably with “cured” or “discharged from care.” None of these uses is quite right, and the gap between the clinical reality of MMI and its administrative and legal applications is where many disputes are born.
This piece is written for three audiences, each of whom needs something slightly different from the concept: physicians who must determine MMI defensibly, attorneys who must test whether that determination was properly made, and claims professionals who must decide what MMI does and does not authorize them to do. I write from the framework of the AMA Guides to the Evaluation of Permanent Impairment, Sixth Edition, and from the clinical practice conventions used across workers’ compensation and independent medical evaluation systems more broadly, and I will address how state-specific terminology and statutory schemes modify the concept’s application.
The Clinical Definition
Maximum medical improvement is the point at which an examinee’s condition has stabilized to the extent that, with or without further treatment, no substantial change, improvement, or worsening is expected over the next year. The concept is central to impairment evaluation because it identifies the point at which a condition is sufficiently stable for permanent impairment to be assessed. The legal consequences attached to MMI, including its relationship to temporary or permanent disability benefits, vary by jurisdiction. Synonyms used across jurisdictions include end of healing, fixed and stable, maximum cure, medical stability, permanent and stationary, and stable and ratable.
“Stabilized” does not mean symptom-free. It means the trajectory of the condition has flattened. A patient may continue to have pain, weakness, or functional limitation at MMI; what has ended is the expectation that further formal medical or surgical intervention will materially change the underlying impairment. MMI is not predicated on the elimination of symptoms or subjective complaints, and a physician who withholds an MMI determination simply because the patient still hurts is applying the wrong standard.
MMI is, at bottom, a medical opinion with potentially substantial administrative and financial consequences attached to it by law. In many systems, it is an important transition point for evaluating permanent impairment and may affect temporary disability benefits, permanent disability determinations, future medical care, and settlement discussions. Those consequences are jurisdiction-specific and should not be inferred from the medical finding alone. Because of the significance of the determination, the examiner’s MMI opinion should be considered, supported, and explicit — not a single unelaborated sentence appended to the end of a report.
Determining MMI Without a Statutory Definition
Many jurisdictions define MMI, or its local equivalent, by statute or administrative regulation, and where such a definition exists, it controls. Where it does not, the criteria I apply are clinical rather than legal, and they converge on a single underlying question: has the condition genuinely stopped changing in a way that matters? Answering that requires looking at whether the treatments reasonably expected to produce further improvement have in fact been completed, and, where an examinee has declined a course of care that remained available and reasonable, whether the condition can nonetheless be expected to remain stable without it. It requires an honest assessment of whether any ongoing improvement is the kind expected to continue meaningfully or has become the sort of incremental variation any chronic condition shows from visit to visit. And it requires confirming that the condition, as it stands, is stable enough that an impairment rating performed today would mean something—that it would not simply need to be redone in six months because the underlying process had not yet settled. When the record supports each of these conclusions, MMI is appropriate, and the reasoning belongs in the report explicitly rather than as a single conclusory sentence standing in for the analysis.
Timing varies considerably by pathology. Some uncomplicated musculoskeletal and soft-tissue injuries may become stable within months, while complex neurologic, spinal cord, traumatic brain, multisystem, or catastrophic injuries may require substantially longer periods of recovery and rehabilitation. No single timetable establishes MMI. The appropriate interval depends on the underlying pathology, treatment course, expected natural history, objective findings, and whether further meaningful improvement in the impairment is reasonably anticipated.
MMI Is Not a Single Universal Term
One source of confusion in medicolegal practice is that MMI goes by many names depending on jurisdiction, as noted above. The underlying clinical concept is substantially similar across these labels, but the statutory definitions and consequences attached to them may differ materially. Attorneys and claims professionals working across jurisdictions should never assume that a physician’s use of one term automatically satisfies the statutory definition used in another system. When I am retained on a multi-jurisdictional file, I make a point of using the terminology the controlling statute or regulation requires and defining it explicitly in the report, rather than relying on the reader to translate between vocabularies.
MMI and Permanency Are Closely Related but Not Identical
Permanency describes an impairment that is static or well stabilized and unlikely to remit despite treatment, within reasonable medical probability. In practice, the two terms are frequently used synonymously, and MMI typically occurs when all reasonable medical treatment expected to produce further improvement has been offered or provided. Where the concepts diverge is with dynamic, systemic, or progressive conditions; certain organ-based or degenerative diseases are never truly “at permanency” in the strict sense, because ongoing decline is anticipated as part of the natural history of the disease. In those cases, the evaluating physician must document the expected trajectory and explain why an impairment rating is nonetheless being assigned at a defined point in time, consistent with the disease’s known natural history in the medical literature.
Why MMI Is the Gatekeeper for Impairment Rating
The single most important procedural fact about MMI, from a medicolegal standpoint, is this: only permanent impairment may be rated under the AMA Guides, and only after MMI has been determined. An impairment rating performed before a patient reaches MMI is premature and inconsistent with the Guides’ methodology because the framework assumes the condition being measured is sufficiently stable. This is why a defensible medicolegal report should include an explicit MMI determination, with supporting clinical reasoning, before assigning a percentage impairment. When I review a report that assigns whole-person impairment without addressing whether or when MMI was reached, I regard that omission as an important methodological deficiency.
Determining that a reasonable time has passed for healing or recovery requires clinical judgment calibrated to the specific pathology. Peripheral nerve injuries, for example, may continue to demonstrate physiologic recovery for an extended period, particularly when axonal regeneration and reinnervation are involved. MMI should therefore be determined from the nature and severity of the lesion, the treatment course, serial clinical or electrodiagnostic findings when available, and whether further meaningful change in permanent impairment is reasonably anticipated. No fixed number of visits or predetermined interval between examinations establishes MMI. MMI does not require that every last increment of biological healing has occurred; it requires that the condition be sufficiently stable and that further formal medical or surgical intervention not be expected to substantially improve the underlying impairment within medical probability.
Where MMI Determinations Go Wrong
Several recurring errors distort MMI opinions in practice, and recognizing them is as important for the attorney or claims professional reviewing a report as it is for the physician writing one.
MMI Concerns the Underlying Condition, Not Symptoms or Ongoing Care
The most persistent misconception, held by examinees and, on occasion, less experienced claims handlers, is that MMI cannot be found so long as the patient still reports pain or continues to receive any care at all. Neither proposition is correct. A patient can be at MMI with a significant, permanent whole-person impairment and continuing symptoms; what has stabilized is the underlying condition, not necessarily the patient’s subjective experience of it. Likewise, ongoing medication management, a home exercise program, periodic follow-up, and some maintenance or palliative procedures may be entirely compatible with MMI when they are intended to maintain function or control symptoms rather than produce substantial improvement in the underlying permanent impairment. The question is narrower than whether treatment is still occurring: it is whether treatment being provided, or reasonably remaining to be provided, is expected to materially change the condition in a way the impairment rating would need to reflect.
Declining an Available Treatment Does Not Automatically Defeat MMI
A related error assumes that MMI cannot be reached unless every conceivable treatment avenue has been pursued to exhaustion. That is not the standard. Patients may decline surgery, injections, medications, or rehabilitation for a variety of reasons, and an examiner is not required to hold the file open indefinitely merely because an unpursued option exists. When a reasonable and available treatment has been declined or treatment noncompliance limits recovery, the report should identify the recommended treatment, address its suitability and the basis for refusal or noncompliance, and explain that MMI is being determined in the context of treatment not being pursued.
Different Conditions May Reach MMI at Different Times
An organizational error I see often in multi-region claims is the assumption that every condition arising from a single event must become medically stable on the same date. Clinically, that need not be true. A worker who fractured a wrist and tore a rotator cuff in the same fall may reach a stable, ratable state in the wrist well before the shoulder, which may still be awaiting surgery or progressing through a longer postoperative course. The examiner should identify the MMI status of each condition or body region when medically relevant, while recognizing that the controlling jurisdiction determines whether those individual medical findings translate into one claim-level MMI date, several legally operative dates, or different benefit consequences.
MMI Reflects Today’s Clinical Picture, Not a Guarantee About Tomorrow’s
Finally, MMI is sometimes treated as a permanent, unrevisable ruling once entered, as if reaching it closed a door that cannot reopen. It carries no such medical finality. A condition thought to be stable can later reactivate, a complication can emerge, or the expected natural history can include later progression. None of these developments necessarily means the original MMI opinion was wrong when it was given. The Sixth Edition does not permit rating anticipated future impairment; the physician rates the individual’s current permanent impairment and may document the potential for later progression. A properly supported MMI opinion is therefore a statement about the examinee’s condition as of the relevant evaluation date, not a guarantee that the condition will never change.
Prognosis: A Distinct but Related Opinion
MMI answers whether a condition has become sufficiently stable for permanent impairment assessment. Prognosis is the companion opinion, addressing the expected future course and what the condition is likely to require going forward. The two are often requested, but they are not interchangeable. Where prognosis is within the scope of the referral, it deserves analysis comparable in rigor to the MMI determination because it may materially affect future medical planning, functional expectations, disability analysis, and settlement considerations.
I find it useful to separate the biological question from the functional one, because they do not always move together. Whether the underlying pathology itself is stable, likely to progress, or prone to fluctuate is a question about the disease or injury process; a degenerative joint, for instance, may be expected to worsen slowly over years even while the examinee’s current impairment rating reflects only today’s findings. The functional question is different and sometimes moves independently: a patient can continue to gain function through conditioning and adaptation even after the anatomic injury itself has plateaued, or can be expected to lose function over time despite a structurally unchanged picture, particularly where deconditioning, aging, or a sedentary occupation compounds a stable anatomic deficit.
From there, a defensible prognosis should say something concrete about the care the patient is likely to need, not simply that ongoing treatment may be beneficial, but, when reasonably predictable, what type of care is anticipated, at what approximate frequency, and for how long. The physician’s principal responsibility is to identify the medical necessity, nature, frequency, and duration of anticipated future care. A life care planner or other appropriately qualified expert often addresses detailed economic costing, particularly when formal lifetime cost projections are required, although the appropriate division of responsibility depends on the physician’s expertise and the scope of the referral.
A prognosis is also incomplete without naming what could move the outcome in either direction: compliance with a home program, avoidance of reinjury, or control of a comorbidity such as diabetes or obesity that is known to slow healing and worsen outcomes. Some injuries have a natural history well documented across large populations, and a prognosis for those can be offered with real confidence. Others vary enormously from one patient to the next, and an examiner does the reader a disservice by presenting that kind of uncertain course with the same tone of certainty used for a well-charted one. Stating the confidence level explicitly, rather than leaving the reader to infer it from the physician’s tone, is itself part of a rigorous prognosis.
What Attorneys Should Look For in a Medicolegal Record
When reviewing a treating physician’s records or an independent medical evaluation for MMI-related issues, I recommend attorneys ask a consistent set of questions. Has the physician stated an MMI date and explained, in clinical terms specific to this patient’s condition, why that date was chosen rather than an earlier or later one? Does the record reflect that a reasonable healing period, consistent with the nature of the pathology, actually elapsed? Is the MMI determination supported by objective findings, the longitudinal clinical record, and evidence of stability over time where serial evidence is available, or is it a conclusory statement unsupported by the medical record? Where multiple body regions or conditions are involved, does the report address each on its own clinical timeline? And, where prognosis is within the scope of the referral, does the report address the expected biological and functional trajectory, anticipated future care, factors that could alter the course, and the degree of medical certainty appropriate to the available evidence?
A physician’s failure to address these questions does not necessarily mean the MMI opinion is wrong, but it does mean the opinion is not adequately supported, and an unsupported opinion is vulnerable in deposition or at trial.
What Claims Professionals Should Understand About the Administrative Consequences
For claims professionals, MMI commonly functions as an important trigger point, but its exact administrative effect depends on the governing law. In many jurisdictions, it is associated with the transition from temporary disability issues to consideration of permanent impairment, permanent disability, or settlement, but it should not be assumed that every temporary benefit automatically ends on the MMI date. This administrative function is a legal and statutory overlay on top of the clinical concept, not a restatement of it. Impairment ratings are one input into a determination of disability, work capacity, or benefit entitlement, but they are not, by themselves, that determination. A claims professional who receives an MMI date and a whole-person impairment percentage has received important medical evidence for the subsequent legal or administrative determination, not the determination itself.
It is equally worth remembering that an MMI determination does not, by itself, resolve questions of causation, apportionment, work capacity, future medical care, or benefit entitlement. Those are analytically distinct issues that must be addressed under the applicable medical and legal framework. The physician should distinguish the current impairment attributable to the condition being evaluated from preexisting, subsequent, or unrelated conditions when causation or apportionment is within the scope of the assignment. And where a file involves multiple body regions or diagnoses at different stages of recovery, the claims professional should expect the medical report to identify the MMI status of each relevant condition rather than assume that clinical stability necessarily occurred everywhere on a single date.
A Final Word on Rigor
If there is one theme I would like every reader, physician, attorney, or claims professional, to take from this discussion, it is that MMI is not a formality to be recited but a substantive medicolegal finding that must be reasoned, documented, and defensible to a reasonable degree of medical probability. The physician’s obligation is to explain why, clinically, this patient’s condition has stabilized at this point in time, using objective findings, the known natural history of the condition, and an honest accounting of what further treatment, if any, remains available, paired with a prognosis of comparable rigor. The attorney’s obligation is to test that reasoning rather than accept the conclusion at face value. The claims professional’s obligation is to understand what MMI does and does not authorize, and to resist the temptation to treat a stabilization finding as equivalent to full recovery or as a bar to all future medical involvement.
Handled with that rigor, MMI serves its intended function well: it provides a fair, medically grounded point at which the acute and subacute phases of recovery give way to a considered, evidence-based assessment of permanent impairment, one that can withstand scrutiny in a hearing room, a settlement negotiation, or a courtroom
References
- AMA Guides to the Evaluation of Permanent Impairment, Sixth Edition (2008): Sections 2.3c, 2.5e, 2.5f
- Brigham CR et al. Independent Medical Evaluation Best Practices. AMA Guides Newsletter. Sep/Oct 2017
About the Author
Dr. Waqas Ahmad Buttar, MBBS, MHA, CIR
Dr. Buttar serves as Medical Director for WorkCompCollege.com, bringing more than 19 years of experience spanning clinical medicine, healthcare administration, medicolegal consulting, and impairment evaluation. A Certified Impairment Rater in both the Fifth and Sixth Editions of the AMA Guides to the Evaluation of Permanent Impairment, Dr. Buttar is widely recognized for his expertise in permanent impairment ratings, causation analysis, apportionment, workability assessments, and complex compensation claims. He has worked closely with internationally respected impairment expert Christopher R. Brigham, MD, contributing to AMA Guides education, medicolegal analysis, and workers’ compensation consulting initiatives. Prior to his medicolegal focus, Dr. Buttar served in progressively responsible clinical and administrative leadership roles within a 550-bed tertiary care teaching hospital, where he managed inpatient and outpatient care, participated in multidisciplinary medical boards, conducted functional capacity and work-related health evaluations, and helped oversee hospital operations and quality initiatives. In addition to supporting U.S.-based workers’ compensation and medicolegal evaluations, Dr. Buttar serves as a medical consultant to the United Nations, conducting impairment evaluations and compensation reviews involving injuries, illnesses, disability, and death. His unique combination of frontline clinical experience, healthcare leadership, global compensation systems expertise, and deep knowledge of the AMA Guides makes him a valuable resource for professionals seeking to navigate the complex intersection of medicine, impairment, and workers’ compensation.
